Monoclonal Anti-FKHR (FOXO1a) antibody produced in mouse, clone FKH 117, purified immunoglobulin, buffered aqueous solution

Code: F6928-200UL D2-231

Not available outside of the UK & Ireland.

Application

Monoclonal Anti-FKHR antibody has been used in:immunoblotting enzyme linked immunosorbent assay (ELISA)immunoprecipitation

Monoclonal Anti-FKHR (FOXO1a) ant...


 Read more

Your Price
$515.59 200UL
Discontinued

Not available outside of the UK & Ireland.

Application

Monoclonal Anti-FKHR antibody has been used in:immunoblotting enzyme linked immunosorbent assay (ELISA)immunoprecipitation

Monoclonal Anti-FKHR (FOXO1a) antibody is suitable for immunoblot assay to study the down-regulation of both p16INK4A and p14ARF expression, and immunoblot of SKMCs and HSMM cells in a study of stable ectopic expression of PAX3-FKHR in low passage primary human skeletal muscle cells. It is also suitable for microarray and indirect ELISA.

Biochem/physiol Actions

FKHR plays a key regulatory roles in embryonic development, differentiation, apoptosis, and tumorigenesis. It was first identified at chromosomal breakpoints in human tumors and consequently linked to tumorigenesis. The activity of FKHR is regulated by growth factors via the PKB/PI3K pathway. The expression of FKHR is inhibited through phosphorylation by PKB. Within the nucleus, the dephosphorylated FKHRL1 induces expression of target genes such as Fas ligand, and triggers apoptosis. It is involved in apoptosis, glucose homeostasis, cell cycle regulation and as a nuclear receptor co factor. It has been found that FKHR also play a role in endometrial differentiation via the protein kinase A (PKA) pathway.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

General description

Monoclonal Anti-FKHR (FOXO1a) (mouse IgG1 isotype) is derived from the FKH117 hybridoma produced by the fusion of mouse myeloma cells and splenocytes from BALB/c mice immunized with a synthetic peptide corresponding to human FKHR, conjugated to KLH.

FKHR belongs to the superfamily of forkhead transcription factors (FOX). It is characterized by a common Forkhead (or winged helix) domain, a variant of the helix-turn-helix motif. FKHR contains three residues, Thr24, Ser256, and Ser319 that lie within consensus sequences for phosphorylation by protein kinase B (PKB).

Immunogen

synthetic peptide corresponding to human FKHR (amino acids 636-651), conjugated to KLH.

Packaging

200 µL in glass bottle

Physical form

Solution in 0.01 M phosphate buffered saline, pH 7.4, containing 15 mM sodium azide.

antibody formpurified immunoglobulin
antibody product typeprimary antibodies
biological sourcemouse
cloneFKH 117, monoclonal
conjugateunconjugated
formbuffered aqueous solution
Gene Informationhuman ... FOXO1(2308)
isotypeIgG1
mol wtantigen 70-75 kDa
Quality Level200
shipped indry ice
species reactivityhuman
storage temp.−20°C
technique(s)indirect ELISA: suitable, microarray: suitable, immunoprecipitation (IP): suitable, western blot: 0.5-1 µg/mL using total extract of COS-7 cells transfected with FKHR expression plasmid
UniProt accession no.Q12778
This product has met the following criteria to qualify for the following awards:



HAVE AN ACCOUNT? LOGIN

GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.